Release 4B Ballot #1

This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationdispense0317

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Patient, Practitioner

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationDispense.

Generated Narrative

status: stopped

medication:

code: Adcetris (Brentuximab Vedotin 50mg/10.5ml)

manufacturer: Generated Summary: active; name: Acme Corporation

form: Lyophilized powder for injectable solution (qualifier value)

subject: Donald Duck . Generated Summary: Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male

Performers

-Actor
*Generated Summary: id: 937223645 (OFFICIAL), id: 134IDY41W988 (USUAL); Rob van den Berk (OFFICIAL); Phone: 0205569288, R.A.vandenberk@bmc.nl, Fax: 0205664987; gender: male; birthDate: 1975-12-07

authorizingPrescription: Generated Summary: id: 12345689 (OFFICIAL); status: completed; intent: order; ?ngen-3; authoredOn: 2015-01-15; instantiatesUri: http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf

type: Trial Fill

quantity: 3 415818005

daysSupply: 1 Day

whenPrepared: 25 Jun. 2015, 12:13:00 pm

whenHandedOver: 26 Jun. 2015, 12:13:00 pm

DosageInstructions

-
*

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.